A bifunctional urease mutant for degrading urea and ethyl carbamate and its application
By performing specific amino acid mutations in the urease structural gene, the temperature stability and ethanol tolerance of urease are improved, and the problem of the reduction of existing urease activity in high temperature and high ethanol environments is solved, and the efficiency of urethane is achieved Degradation, suitable for applications in the food industry.
Patent Information
- Application Number
- CN202310624233.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-05-30
- Publication Date
- 2024-11-01
- Estimated Expiration
- 2043-05-30
AI Technical Summary
The existing urease is unstable in acidic or ethanol-high concentration environments, making it difficult to effectively degrade synthetic ethyl carbamate, and the poor ethanol tolerance limits its industrial application in the food industry.
A bifunctional urease mutant was designed to improve the temperature stability and ethanol tolerance of the enzyme by performing amino acid mutations at specific locations in the structural gene (such as G100L, A247I, V356N, I468C) and enhance its temperature stability and ethanol tolerance at high temperatures and Activity under high ethanol conditions.
The enzyme activity of the mutant is maintained at a high temperature of 70°C and the enzyme activity is significantly increased when the ethanol concentration is not higher than 40%. It is expected to be better used in fermented foods and beverages to degrade ethyl carbamate.
Smart Images

Figure CN116855482B_ABST
Abstract
Description
Technical Field
[0001] The invention relates to a bifunctional urease mutant for degrading urea and ethyl carbamate and application thereof, belonging to the technical field of genetic engineering and enzyme engineering. Background Art
[0002] Ethyl carbamate (Urethane, Ethyl carbamate), also known as urethane, is a toxic substance with potential carcinogenic and genotoxic risks to humans. It is produced during the storage and transportation of a variety of fermented foods. Initially, ethyl carbamate was found to inhibit the growth of bacteria and mouse tumor cells and was used as an anti-tumor drug (Urethan (ethyl carbamate) as a cosolvent of drugs commonly used parenterally in humans). However, in 1943, people found that ethyl carbamate could cause mouse cells to become cancerous, so it was stopped (Cytochrome P450 2E1 (CYP2E1) is the principal enzyme responsible for urethane metabolism: comparative studies using CYP2E1-null and wild-type mice.). Furthermore, studies have found that ethanol in alcoholic beverages can enhance the carcinogenicity of ethyl carbamate, so the ethyl carbamate content in alcoholic beverages such as rice wine, white wine, wine, sake, and brandy has attracted more and more attention, which is related to important issues such as food safety and whether alcoholic beverages can be consumed continuously and for a long time. These issues have attracted the attention of governments and organizations in various countries to the EC content, and they have formulated limits on the EC content (the influence of nitrogen metabolism regulatory factor Dal80p on the formation of ethyl carbamate in rice wine brewing). Canada was the first to limit the maximum concentration of this substance in alcoholic beverages, and the International Agency for Research on Cancer also listed it as a Class 2A carcinogen. At present, the limit of ethyl carbamate content in rice wine exported to my country by European and American countries is 100μg / L, but the ethyl carbamate content in rice wine produced in my country is about 100-750μg / L, which not only restricts the export of wine, but also causes food safety concerns for people who drink it for a long time (Expression, molecular modification and use of Bacillus paralicheniformis acid urease for the reduction of ethyl carbamate in rice wine).
[0003] The main precursors of ethyl carbamate in fermented foods are: carbamyl compounds, cyanide, diethyl pyrocarbonate, urea and citrulline. These substances react with ethanol under acidic heating conditions to form ethyl carbamate. Some of these precursors are added as raw materials or naturally contained in the raw materials, such as: the production raw materials of distilled liquor contain cyanide and diethyl pyrocarbonate, which was once used as a preservative. The formation of ethyl carbamate can be reduced by controlling the addition. Urea produced by the arginine synthesis pathway in the metabolic pathway of brewer's yeast in rice wine is the main cause of the production of ethyl carbamate. The main measures to control ethyl carbamate include process optimization, metabolic engineering and enzyme methods (A REVIEW: Arginine metabolism in wine lactic acid bacteria and its practical significance). The process optimization method mainly includes three aspects. The first is to pre-treat the raw materials. The content of precursors such as citrulline and glutamic acid in the raw materials can be reduced by whitening and multiple washings, but this treatment method will also reduce the nutrients in the raw materials. Second, optimize the temperature, pH, fermentation time, etc. during the fermentation process. Third, optimize the finished product obtained after fermentation, including shortening the heating time for sterilization and adsorbing ethyl carbamate in alcoholic beverages through materials with adsorption functions. These methods may affect the flavor of alcoholic beverages or have low efficiency in reducing ethyl carbamate. Metabolic engineering modification mainly targets arginase in brewer's yeast. Some studies screened arginase-deficient mutants on specific culture media to reduce the urea produced after arginine degradation; some studies knocked out genes for transporting and metabolizing arginine; some studies strengthened the genes for cell utilization and absorption of urea. These methods reduced the production of urea and enhanced its utilization by cells, but could not deal with the problem of ethyl carbamate generated by substances other than urea. Enzymatic control refers to the use of acid urease and ethyl carbamate hydrolase, which can hydrolyze urea and ethyl carbamate into ethanol, carbon dioxide and ammonia respectively, which is an effective and mild reaction. Urease can effectively reduce urea, the precursor of ethyl carbamate, so as to achieve the goal of controlling the content of ethyl carbamate. Currently, many countries allow the addition of urease to alcoholic beverages, but most ureases cannot degrade synthesized ethyl carbamate. Ethyl carbamate hydrolase can directly and efficiently hydrolyze ethyl carbamate. Many researchers at home and abroad also hope to stably express the enzyme heterologously, but it is very unstable in acidic or high ethanol concentration environments, resulting in it not being used in practice. Since the formation mechanism of ethyl carbamate is very complex and its structure is very stable, it is a more appropriate method to use finished enzymes to directly hydrolyze it.
[0004] At present, the enzymes with resolved amino acid sequences reported in the literature all have the problem of poor ethanol tolerance, such as a kind of amidotransferase purified from lysine Bacillus by Li Jingjing, which has poor ethanol tolerance (separation and purification of ethyl carbamate hydrolase and enzymatic properties), and can only retain about 10% of enzyme activity at an ethanol concentration of 15%. In addition, enzymes, as a protein with catalytic activity, are susceptible to the influence of various factors and lose their activity, and high temperature can cause hydrogen bonds or hydrophobic bonds to be destroyed, thereby affecting the stability of urease. Therefore, it is urgent to improve the ethanol tolerance and thermal stability of urease to meet the requirements of industrial application of urease. Summary of the invention
[0005] In order to solve the above problems, the present invention provides a bifunctional urease mutant that can degrade both urea and ethyl carbamate, and has significantly improved ethanol tolerance and temperature stability.
[0006] The first object of the present invention is to provide a bifunctional urease mutant for degrading urea and ethyl carbamate, wherein the bifunctional urease mutant is obtained by mutation of the bifunctional urease, wherein:
[0007] The gene cluster of the bifunctional urease includes a structural gene, wherein the structural gene includes ureA with an amino acid sequence as shown in SEQ ID NO.1, ureB with an amino acid sequence as shown in SEQ ID NO.2, and ureC with an amino acid sequence as shown in SEQ ID NO.3;
[0008] The mutation is to mutate the glycine at position 100 of the sequence shown in SEQ ID NO.3 to leucine, or to mutate the alanine at position 247 to isoleucine, or to mutate the valine at position 356 to asparagine, or to mutate the isoleucine at position 468 to cysteine.
[0009] Furthermore, the gene cluster of the bifunctional urease also includes auxiliary genes ureE, ureF, ureG, ureD and ureH.
[0010] Furthermore, the amino acid sequence of the auxiliary gene ureE is shown in SEQ ID NO.4, the amino acid sequence of the auxiliary gene ureF is shown in SEQ ID NO.5, the amino acid sequence of the auxiliary gene ureG is shown in SEQ ID NO.6, the amino acid sequence of the auxiliary gene ureD is shown in SEQ ID NO.7, and the amino acid sequence of the auxiliary gene ureH is shown in SEQ ID NO.8.
[0011] The second object of the present invention is to provide a gene encoding the bifunctional urease mutant.
[0012] The third object of the present invention is to provide a recombinant plasmid carrying the gene.
[0013] Furthermore, the vector of the recombinant plasmid includes but is not limited to pET-28a, pET-28b, pET-20b and the like.
[0014] The fourth object of the present invention is to provide a host cell expressing the bifunctional urease mutant.
[0015] Furthermore, the host cell is a bacterium, a fungus, a plant cell or an animal cell.
[0016] Furthermore, the bacteria is Escherichia coli, preferably E. coli BL21 (DE3).
[0017] The fifth object of the present invention is to provide the use of the above-mentioned bifunctional urease mutant, gene, expression vector or host cell in the degradation of ethyl carbamate.
[0018] The sixth object of the present invention is to provide the use of the above-mentioned bifunctional urease mutant, gene, expression vector or host cell in preparing food.
[0019] Furthermore, the food includes alcoholic beverages, and the bifunctional urease can be used to degrade ethyl carbamate in the alcoholic beverages.
[0020] The seventh object of the present invention is to provide a method for degrading ethyl carbamate, using a bifunctional urease mutant or an expression system containing the bifunctional urease mutant for degradation.
[0021] Furthermore, the temperature during degradation is not higher than 80°C.
[0022] Further, when ethyl carbamate is degraded in alcoholic beverages, the ethanol concentration is not higher than 40% v / v.
[0023] Beneficial effects of the present invention:
[0024] The thermal stability of the bifunctional urease mutants provided by the present invention is improved, wherein the mutants I468C, G100L, A247I, and V356N retain residual enzyme activity at more than 70% even when kept at a high temperature of 70°C. In addition, the ethanol tolerance of the bifunctional urease mutants provided by the present invention is also improved, wherein the relative enzyme activity of the mutants I468C, G100L, A247I, and V356N under 30% ethanol conditions is increased from 35.4% before mutation to 60.3%, 59.8%, 51.2%, and 55.2%, respectively. At the same time, the enzyme activity of the mutant is also improved to a certain extent compared with the wild type (wherein the enzyme activity of the mutant I468C with EC as a substrate is increased from 2.93U / ml of the wild type to 7.03U / ml), and it is expected that it can be better applied to fermented foods and fermented alcoholic beverages. BRIEF DESCRIPTION OF THE DRAWINGS
[0025] Figure 1 This is the screening result of bifunctional urease mutants;
[0026] Figure 2 The effect of temperature on the activity of wild-type and mutant enzymes;
[0027] Figure 3 The effect of ethanol on the activity of wild enzyme and mutant enzyme. DETAILED DESCRIPTION
[0028] The present invention is further described below in conjunction with the accompanying drawings and specific embodiments so that those skilled in the art can better understand the present invention and implement it, but the embodiments are not intended to limit the present invention.
[0029] The urease structure of the present invention is as follows:
[0030] The gene sequence of urease includes structural genes and auxiliary genes, wherein three structural genes constitute an active center to degrade urea and ethyl carbamate, and auxiliary genes assist the expression of structural genes and modify structural gene proteins to help metal ions transfer to the active center. The bifunctional urease in the present invention has three structural genes ureA ureBureC and five auxiliary genes ureD ureE ureF ureG ureH, and the arrangement order of these genes on the genome is: ureA ureB ureC ureE ureF ureG ureD ureH. The present invention modifies the structural gene ureC of the bifunctional urease to improve its temperature stability and ethanol tolerance.
[0031] The sequence involved in the present invention is as follows:
[0032] The amino acid sequence of the structural gene ureA is shown in SEQ ID NO.1.
[0033] The amino acid sequence of the structural gene ureB is shown in SEQ ID NO.2.
[0034] The amino acid sequence of the structural gene ureC is shown in SEQ ID NO.3.
[0035] The amino acid sequence of the auxiliary gene ureE is shown in SEQ ID NO.4.
[0036] The amino acid sequence of the auxiliary gene ureF is shown in SEQ ID NO.5.
[0037] The amino acid sequence of the auxiliary gene ureG is shown in SEQ ID NO.6.
[0038] The amino acid sequence of the auxiliary gene ureD is shown in SEQ ID NO.7.
[0039] The amino acid sequence of the auxiliary gene ureH is shown in SEQ ID NO.8.
[0040] In the present invention, an experiment is performed to verify whether the stability of the target mutant is increased, comprising the following steps:
[0041] S1. Perform site-directed mutagenesis on the plasmid expressing the protein to obtain a plasmid capable of expressing the mutant; and introduce the plasmid into Escherichia coli BL21;
[0042] S2, first culture the seed solution in 20 mL of LB medium overnight;
[0043] S3, then inoculated with 3% of the seed liquid into TB expression medium for expression, wherein at OD 600 =0.4, add IPTG, adjust the culture temperature to 4°C, and express for 18 h;
[0044] S4. Collect the strains by centrifugation, break them in an ice bath, and collect the supernatant by centrifugation to obtain the crude enzyme solution.
[0045] Example 1 Screening of bifunctional urease mutants
[0046] In this example, the crystal structure of B. pasteurii urease UreC is used as a template (PDB ID, 2UBP c), and its structure is simulated in 3D using Discovery Studio software. In Gromacs (version 2019.03), water molecules and ethanol molecules are used as the system for molecular dynamics simulation. TIP4P is directly used for the water model, and the ethanol model uses a manually added ethanol small molecule model and calculates the number of ethanol molecules and water molecules according to the ethanol concentration. After energy minimization and constant temperature constant system ensemble (NVT) equilibrium, the system is gradually raised from atmospheric pressure to the expected high pressure through Parrinell-Rahman pressure coupling. After the system is balanced, the restrictions are removed for finished product simulation, and finally the results are analyzed. To ensure the repeatability of the results, all simulations are repeated three times for a duration of 30ns. In this example, the RMSD and RMSF of the protein and its mutants are executed by Gromacs's own program, the secondary structure of the protein is calculated by DSSP, and the structural analysis of the bifunctional urease is performed using PYMOL 2.0.
[0047] The secondary structure that has the greatest impact on stability in proteins is the loop region. In order to analyze the fluctuation of protein stability during the simulation process, the loop region on the bifunctional urease was selected for RMSF and RMSD calculation. The structure with a large difference in fluctuation between the simulation time and the overall protein was selected for analysis. The results showed that amino acids 90-112, 220-250, 354-367 and 451-499 of the protein were loop regions with large differences in RMSF and RMSD from the overall amino acids, so these four structures were selected as key regions for mutation, and the amino acids in this region were subjected to virtual saturation mutation to construct a mutant library. In order to avoid the possibility that the acidic and basic amino acids may affect the original salt bridge after mutation, thereby reducing the stability of the protein, all acidic and basic amino acids in the region were first excluded, and the remaining amino acids were subjected to virtual saturation mutation to form a mutant library.
[0048] The free energy change of mutants was calculated by FoldX, and mutants with ΔΔG (ΔGmutant-ΔGwild) less than 0 were screened. In order to improve the success rate of mutant screening, false positive mutants in the mutant library should be excluded as much as possible. Therefore, I-Mutant was used to rescreen the positive mutants screened by FoldX, and mutants with improved stability calculated by both software were selected for experimental verification. The results of FoldX screening and I-Mutant rescreening are shown in Figure 1 In this heat map, the bluer the color, the lower the free energy after mutation, that is, the more stable it is. The sites with improved stability in both screening methods are selected: G100L, A247I, V356N, and I468C.
[0049] Example 2 Preparation of bifunctional urease mutants
[0050] The selected mutation site was designed with a site-directed mutagenesis primer. The template was the UH fragment connected to the pET20b plasmid. The mutant primer was used to amplify it. The primer sequence is shown in Table 1. The amplified fragment was phosphorylated to prevent the unmutated plasmid from reconnecting and forming a false positive plasmid. Then the fragment was recombined. The recombined plasmid can be directly transformed into the BL21 (DE3) competent state. After culturing at 37°C for half an hour, it was coated on a plate with ampicillin resistance to screen positive transformants. After picking bacteria from the plate, it was transferred to LB liquid culture medium and cultured for 12 hours. After that, it was transferred to a glycerol tube and kept in a refrigerator at -80°C. Samples were sent to Shanghai Bioengineering Co., Ltd. for sequencing verification. The strain with the correct sequencing result was inoculated from the glycerol tube into LB liquid culture medium containing ampicillin resistance at 37°C and 200r / min for 12 hours to activate the strain. Then it was transferred to LB liquid culture medium containing ampicillin resistance at 37°C and 200r / min for 12 hours as the seed liquid for protein expression. The seed solution was transferred to the expression medium TB at a 3% inoculum volume and cultured at 37°C and 200 r / min until the OD 600 was 0.6, IPTG was added to a final concentration of 0.1 mmol / L, and cultured at 16°C and 200 r / min for 18 h.
[0051] Table 1 Primer sequences for constructing mutants
[0052]
[0053] The recombinant bacterial solution was centrifuged at 4°C and 8000r / min for 10min, and the bacteria were collected. The bacteria were washed and resuspended with 20mmol / L, pH 7.0 phosphate buffer, and ultrasonically disrupted for half an hour at a power of 405W, with a break of 2s and a stop of 2s. The disrupted bacterial solution was centrifuged at 4°C and 10000r / min for 40min and the supernatant was collected. After passing through the membrane, it was used as the sample. During purification, the pipeline was first flushed with phosphate buffer containing 20mmol / L imidazole and the nickel column was balanced, and then the sample was loaded, and the protein was gradient eluted with phosphate buffer containing 500mmol / L imidazole. The eluate with enzyme activity was collected and desalted and concentrated using an ultrafiltration tube.
[0054] Example 3 Enzyme activity determination method
[0055] Bifunctional urease can hydrolyze ethyl carbamate into ammonia, ethanol and carbon dioxide. Ammonia reacts with phenol-sodium hypochlorite to form indophenol blue. 625The OD value is measured under the conditions to determine the amount of ammonium ions generated in the reaction, so as to determine the enzyme's ability to hydrolyze ethyl carbamate. Therefore, the definition of enzyme activity is: the amount of enzyme required to decompose 1μmol of ethyl carbamate per 1min under the conditions of 37℃ and pH7.0 is one enzyme activity unit. The experiment requires the preparation of two color developers. The preparation method of color developer I is: weigh 15g phenol and 0.625g sodium nitrosoferricyanide, and dilute to 250ml with ultrapure water. The preparation method of color developer II is: weigh 13.125g sodium hydroxide and 7.5ml sodium hypochlorite, and dilute to 250ml with ultrapure water. The reaction conditions are as follows: 100 μl enzyme solution and 100 μl 3% urethane solution are reacted at 37°C for 15 min, 1 ml 10% trichloroacetic acid is added to terminate the reaction, and then 1 ml color developer I and 1 ml color developer II are added, mixed and kept in a 37°C water bath for 20 min, and the absorbance at 625 nm is measured. Enzyme activity = ΔOD 625 ×n×k / 15 to calculate the enzyme activity, where ΔOD 625 is the difference between the absorbance values of the sample and the blank control, n is the dilution factor of the enzyme solution, k is the reciprocal of the slope of the standard curve, and 15 is the reaction time.
[0056] Example 4 Improved thermal stability of bifunctional urease mutants
[0057] The enzyme activity and concentration of the purified enzyme solution were measured, and the results are shown in Table 2:
[0058] Table 2 Specific enzyme activities of wild-type bifunctional urease and mutants
[0059]
[0060] (1) Optimum temperature:
[0061]
[0062] As can be seen from the above table, the optimal reaction temperatures of the single point mutants G100L and A247I are the same as those of the wild type, while the optimal reaction temperatures of the other two single point mutants V356N and I468C are increased by 5°C and 8°C respectively compared with the wild type.
[0063] (2) After the purified wild-type enzyme and its mutants were incubated at different temperatures for a period of time, their residual enzyme activity was measured, and the thermal stability was tested under different temperature conditions, with the enzyme activity before treatment as 100%. The results are as follows:
[0064]
[0065] The wild-type protein was relatively stable under the incubation condition below 50°C, but after incubation at 60°C for 1 h, the residual enzyme activities of G100L, A247I, V356N, and I468C were increased by 4.1%, 2.1%, 5.1%, and 4.5%, respectively, compared with 75.1% of the wild-type (see the residual enzyme activities at different temperatures for 1 h). Figure 2 ).
[0066] (3) Determine the T of the wild-type enzyme and the mutant m The results are as follows:
[0067]
[0068] T of G100L, A247I, V356N, I468C and wild-type proteins m The values were 66℃, 60℃, 59℃, 70℃ and 55℃, which were 11℃, 5℃, 4℃ and 15℃ higher than the original enzyme, respectively. The above experimental results can prove that the thermal stability of the mutant protein is improved.
[0069] Example 5 Improved ethanol tolerance of bifunctional urease mutants
[0070] The effect of ethanol on the decomposition ability of enzymes refers to the determination of enzyme activity after mixing the enzyme and ethanol and keeping it warm for a period of time. The purified wild enzyme and its mutants were kept warm for two hours (37°C) under 15% (v / v), 20%, 25%, 30%, 35%, and 40% ethanol conditions, and their residual enzyme activity was calculated. Figure 3 .
[0071] It can be seen that under the condition of 15% ethanol, the residual enzyme activity of the mutants can reach more than 70%, while that of the wild-type enzyme is slightly lower. After the ethanol concentration increases, the activity of the wild-type enzyme decreases significantly, and the residual enzyme activity decreases to about 40% at 25% ethanol concentration. However, the residual enzyme activity of mutants G100L and I468C can be increased to 65%, and that of A247I and V356N is 55% and 60% respectively. Under the condition of higher ethanol concentration, the mutants all show stronger hydrolysis ability than the wild-type enzyme. This result shows that the obtained mutants have the ability to be used to reduce ethyl carbamate in alcoholic beverages.
[0072] The above-described embodiments are only preferred embodiments for fully illustrating the present invention, and the protection scope of the present invention is not limited thereto. Equivalent substitutions or changes made by those skilled in the art based on the present invention are within the protection scope of the present invention. The protection scope of the present invention shall be subject to the claims.
Claims
1. A bifunctional urease mutant for degrading urea and ethyl carbamate, characterized in that: The bifunctional urease mutant is obtained by mutation of the bifunctional urease, wherein: The bifunctional urease is composed of structural subunits UreA, UreB and UreC, the amino acid sequence of the structural subunit UreA is shown in SEQ ID NO.1, the amino acid sequence of the structural subunit UreB is shown in SEQ ID NO.2, and the amino acid sequence of the structural subunit UreC is shown in SEQ ID NO.3; The mutation is to mutate the glycine at position 100 of the sequence shown in SEQ ID NO.3 to leucine, or to mutate the alanine at position 247 to isoleucine, or to mutate the valine at position 356 to asparagine, or to mutate the isoleucine at position 468 to cysteine.
2. A gene encoding the bifunctional urease mutant according to claim 1.
3. The gene according to claim 2, characterized in that: The gene consists of structural genes ureA, ureB, ureC and auxiliary genes ureE, ureF, ureG, ureD and ureH arranged in sequence, and the sequences of genes ureA, ureB, ureC, ureE, ureF, ureG, ureD and ureH are the coding gene sequences of the protein sequences shown in SEQ ID NO.1-8 respectively.
4. A recombinant plasmid carrying the gene according to claim 2 or 3.
5. A host cell expressing the bifunctional urease mutant according to claim 1.
6. Use of the bifunctional urease mutant according to claim 1, the gene according to claim 2 or 3, the recombinant plasmid according to claim 4 or the host cell according to claim 5 in degrading ethyl carbamate.
7. Use of the bifunctional urease mutant according to claim 1, the gene according to claim 2 or 3, the recombinant plasmid according to claim 4 or the host cell according to claim 5 in preparing food.
8. A method for degrading ethyl formate, characterized in that: The degradation is carried out using the bifunctional urease mutant according to claim 1 or an expression system containing the bifunctional urease mutant.
